Treatment-induced hypoxia attenuates Enzalutamide response and promotes resistance in pre-clinical models of prostate cancer

Pamela Maxwell, Melissa LaBonte Wilson, Melanie McKechnie, Chris Armstrong, Chee Wee Ong, Jenny Worthington, David Waugh

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - 2017
Event1st European Alliance for Personalised Medicine Congress 2017 - Belfast, United Kingdom
Duration: 25 Nov 201730 Nov 2017

Conference

Conference1st European Alliance for Personalised Medicine Congress 2017
Country/TerritoryUnited Kingdom
CityBelfast
Period25/11/201730/11/2017

Cite this